Talphera (TLPH) Amortizatization of Intangibles (2011 - 2023)
Talphera's (TLPH) quarterly Amortizatization of Intangibles came in at $100000.0 in Q3 2023, little changed year-on-year from $100000.0 in Q3 2022, and little changed quarter-over-quarter from $100000.0 in Q2 2023.
Talphera (TLPH) Amortizatization of Intangibles (2011 - 2023) Analysis & Trends
Talphera's Amortizatization of Intangibles history runs 13 years deep, the most recent figure standing at $100000.0 for Q3 2023.
- On a quarterly basis, Amortizatization of Intangibles changed 0.0% year-over-year to $100000.0 in Q3 2023; TTM through Jun 2024 was $100000.0, a 66.44% decrease from a year earlier, with the FY2023 full-year figure at $53000.0, down 86.51% from the prior year.
- Amortizatization of Intangibles steadied at $100000.0 in Q3 2023 per TLPH's latest filing, from $100000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $700000.0 in Q2 2022 and bottomed at $38000.0 in Q1 2023.
- The 5-year median for Amortizatization of Intangibles is $154000.0 (2021), against an average of $187631.6.
- Across the five-year window, Amortizatization of Intangibles soared 250.0% in 2022 and sank 85.71% in 2023, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $241000.0 in 2019, then advanced by 2.07% to $246000.0 in 2020, then tumbled by 37.4% to $154000.0 in 2021, then slumped by 61.04% to $60000.0 in 2022, then jumped by 66.67% to $100000.0 in 2023.
- Per Business Quant, the three latest TLPH Amortizatization of Intangibles figures stand at $100000.0 (Q3 2023), $100000.0 (Q2 2023), and $38000.0 (Q1 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1.30 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Talphera | 87.63 Mn | 87.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 38,000.00 |
| Mar 31, 2023 | 38,000.00 |
| Dec 31, 2022 | 60,000.00 |
| Dec 31, 2022 | 60,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 700,000.00 |
| Jun 30, 2022 | 700,000.00 |
| Mar 31, 2022 | 134,000.00 |
| Mar 31, 2022 | 134,000.00 |
| Dec 31, 2021 | 154,000.00 |
| Dec 31, 2021 | 154,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Jun 30, 2021 | 200,000.00 |
| Jun 30, 2021 | 200,000.00 |